59.14
+1.81
+(3.16%)
At close: 4:00:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-29,837.00
-11,458.00
-7,474.00
-4,442.00
Investing Cash Flow
--
-63.00
-394.00
-56.00
-20.00
Financing Cash Flow
--
75,959.00
36,963.00
-583.00
28,059.00
End Cash Position
--
88,157.00
42,089.00
17,344.00
25,618.00
Income Tax Paid Supplemental Data
--
9.00
--
--
--
Interest Paid Supplemental Data
--
--
16.00
--
19.00
Capital Expenditure
--
-63.00
-394.00
-74.00
-20.00
Issuance of Capital Stock
--
--
37,990.00
--
30,292.00
Issuance of Debt
--
--
--
--
131.00
Repayment of Debt
--
--
--
--
-2,450.00
Free Cash Flow
--
-29,900.00
-11,852.00
-7,548.00
-4,462.00
12/31/2020 - 4/29/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6696.TWO Lin BioScience, Inc.
152.00
+4.47%
GYRE Gyre Therapeutics, Inc.
11.74
+3.16%
ELTX Elicio Therapeutics, Inc.
8.50
+5.07%
SYRE Spyre Therapeutics, Inc.
21.79
+4.66%
DNTH Dianthus Therapeutics, Inc.
21.24
+0.66%
6564.TWO Enimmune corporation
26.15
0.00%
6945.TWO AP Biosciences Inc
50.90
+0.20%
IZTC Invizyne Technologies, Inc.
14.42
+3.37%
PRAX Praxis Precision Medicines, Inc.
75.36
+2.81%
ANAB AnaptysBio, Inc.
18.04
+3.32%